TTR and Alzheimer disease: In a different work, administration of resveratrol, to the AD/TTR+/- mouse model, also produced decreased brain Aβ burden and raised plasma TTR concentrations [104], confirming the stabilization hypothesis, whereas administration of resveratrol to a different AD mouse model, although not inducing decreased plaque burden, increased TTR protein concentration in the brain [105].